Table 4 Adverse events (AEs)
Adverse events (AEs) | Bortezomib-containing regimens | Thalidomide-containing regimens |
|---|---|---|
Case (%) | (n = 39) | (n = 22) |
Gastrointestinal symptoms | 23 (60 %) | 7 (31.8 %) |
Infection (bacterial or/and fungal) | 12 (30.8 %) | 14 (63.6 %) |
Peripheral neuropathy | 12 (30.8 %) | 6 (27.3 %) |
Cytopenia | 8 (20.5 %) | 4 (18.2 %) |
Hyperglycemia | 5 (12.8 %) | 5 (22.7 %) |
Thrombosis | 0 | 3 (13.6 %) |
Herpes zoster | 2 (5.1 %) | 0 |
Arrhythmia | 1 (2.6 %) | 1 (4.6 %) |
Rash | 1 (2.6 %) | 1 (4.6 %) |